BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28433605)

  • 1. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Sasaki T; Rivera-Mulia JC; Vera D; Zimmerman J; Das S; Padget M; Nakamichi N; Chang BH; Tyner J; Druker BJ; Weng AP; Civin CI; Eaves CJ; Gilbert DM
    Exp Hematol; 2017 Jul; 51():71-82.e3. PubMed ID: 28433605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication timing alterations in leukemia affect clinically relevant chromosome domains.
    Rivera-Mulia JC; Sasaki T; Trevilla-Garcia C; Nakamichi N; Knapp DJHF; Hammond CA; Chang BH; Tyner JW; Devidas M; Zimmerman J; Klein KN; Somasundaram V; Druker BJ; Gruber TA; Koren A; Eaves CJ; Gilbert DM
    Blood Adv; 2019 Nov; 3(21):3201-3213. PubMed ID: 31698451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
    Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
    Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
    García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
    J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
    Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
    Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.
    Sarmento LM; Póvoa V; Nascimento R; Real G; Antunes I; Martins LR; Moita C; Alves PM; Abecasis M; Moita LF; Parkhouse RM; Meijerink JP; Barata JT
    Oncogene; 2015 Jun; 34(23):2978-90. PubMed ID: 25132270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance.
    Weiland J; Pal D; Case M; Irving J; Ponthan F; Koschmieder S; Heidenreich O; von Stackelberg A; Eckert C; Vormoor J; Elder A
    Leukemia; 2016 Sep; 30(9):1920-3. PubMed ID: 27055873
    [No Abstract]   [Full Text] [Related]  

  • 12. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
    Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
    Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-ALL Xenografts.
    Fuentes P; Toribio ML; González-García S
    Methods Mol Biol; 2021; 2185():215-239. PubMed ID: 33165851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
    Sharma P; Asthana B; Tyagi S
    Leuk Res; 2009 Jul; 33(7):e83-4. PubMed ID: 19237193
    [No Abstract]   [Full Text] [Related]  

  • 18. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia.
    Richter-Pechańska P; Kunz JB; Bornhauser B; von Knebel Doeberitz C; Rausch T; Erarslan-Uysal B; Assenov Y; Frismantas V; Marovca B; Waszak SM; Zimmermann M; Seemann J; Happich M; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Muckenthaler MU; Korbel JO; Bourquin JP; Kulozik AE
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30389682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Jacobs S; Ausema A; Zwart E; Weersing E; de Haan G; Bystrykh LV; Belderbos ME
    Exp Hematol; 2020 Nov; 91():46-54. PubMed ID: 32946982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD7 promotes extramedullary involvement of the B-cell acute lymphoblastic leukemia line Tanoue by enhancing integrin β2-dependent cell adhesiveness.
    Kondoh T; Kuribayashi K; Tanaka M; Kobayashi D; Yanagihara N; Watanabe N
    Int J Oncol; 2014 Sep; 45(3):1073-81. PubMed ID: 24920488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.